These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 1696013)
21. Positive autoregulation of c-myb expression via Myb binding sites in the 5' flanking region of the human c-myb gene. Nicolaides NC; Gualdi R; Casadevall C; Manzella L; Calabretta B Mol Cell Biol; 1991 Dec; 11(12):6166-76. PubMed ID: 1944282 [TBL] [Abstract][Full Text] [Related]
22. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Wickstrom EL; Bacon TA; Gonzalez A; Freeman DL; Lyman GH; Wickstrom E Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1028-32. PubMed ID: 3277186 [TBL] [Abstract][Full Text] [Related]
23. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545 [TBL] [Abstract][Full Text] [Related]
25. Oncogene-targeted antisense oligodeoxynucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment? Nieborowska-Skórska M; Nakashima M; Ratajczak M; Steplewski Z; Calabretta B; Skórski T Folia Histochem Cytobiol; 1994; 32(1):35-40. PubMed ID: 8026602 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474 [TBL] [Abstract][Full Text] [Related]
27. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Gewirtz AM; Calabretta B Science; 1988 Dec; 242(4883):1303-6. PubMed ID: 2461588 [TBL] [Abstract][Full Text] [Related]
28. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells. Ferrari S; Donelli A; Manfredini R; Sarti M; Roncaglia R; Tagliafico E; Rossi E; Torelli G; Torelli U Cell Growth Differ; 1990 Nov; 1(11):543-8. PubMed ID: 2088479 [TBL] [Abstract][Full Text] [Related]
29. Herpes simplex virus 1 late gene expression is preferentially inhibited during infection of the TAF250 mutant ts13 cell line. Dhar S; Weir JP Virology; 2000 Apr; 270(1):190-200. PubMed ID: 10772991 [TBL] [Abstract][Full Text] [Related]
30. An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. Tortora G; Clair T; Cho-Chung YS Proc Natl Acad Sci U S A; 1990 Jan; 87(2):705-8. PubMed ID: 1689049 [TBL] [Abstract][Full Text] [Related]
31. The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element. Nicolaides NC; Correa I; Casadevall C; Travali S; Soprano KJ; Calabretta B J Biol Chem; 1992 Sep; 267(27):19665-72. PubMed ID: 1527086 [TBL] [Abstract][Full Text] [Related]
32. Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. Reiss K; Travali S; Calabretta B; Baserga R J Cell Physiol; 1991 Sep; 148(3):338-43. PubMed ID: 1717494 [TBL] [Abstract][Full Text] [Related]
33. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins. Tantravahi R; Dudek H; Patel G; Reddy EP Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693 [TBL] [Abstract][Full Text] [Related]
34. c-myb transactivates cdc2 expression via Myb binding sites in the 5'-flanking region of the human cdc2 gene. Ku DH; Wen SC; Engelhard A; Nicolaides NC; Lipson KE; Marino TA; Calabretta B J Biol Chem; 1993 Jan; 268(3):2255-9. PubMed ID: 8420994 [TBL] [Abstract][Full Text] [Related]
35. Truncated c-Myb expression in the human leukemia cell line TK-6. Tomita A; Watanabe T; Kosugi H; Ohashi H; Uchida T; Kinoshita T; Mizutani S; Hotta T; Murate T; Seto M; Saito H Leukemia; 1998 Sep; 12(9):1422-9. PubMed ID: 9737692 [TBL] [Abstract][Full Text] [Related]
36. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells. Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628 [TBL] [Abstract][Full Text] [Related]
37. Antisense src expression inhibits U937 human leukemia cell proliferation in conjunction with reduction of c-myb expression. Waki M; Kitanaka A; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S Biochem Biophys Res Commun; 1994 Jun; 201(2):1001-7. PubMed ID: 7516155 [TBL] [Abstract][Full Text] [Related]
39. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo. Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of cell cycle progression by antisense oligodeoxynucleotides. Baserga R; Reiss K; Alder H; Pietrzkowski Z; Surmacz E Ann N Y Acad Sci; 1992 Oct; 660():64-9. PubMed ID: 1340157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]